EP1005910A2 - Tube centrifuge avec élément de séparation à symmétrie cylindrique, garniture et bouchon - Google Patents

Tube centrifuge avec élément de séparation à symmétrie cylindrique, garniture et bouchon Download PDF

Info

Publication number
EP1005910A2
EP1005910A2 EP99124315A EP99124315A EP1005910A2 EP 1005910 A2 EP1005910 A2 EP 1005910A2 EP 99124315 A EP99124315 A EP 99124315A EP 99124315 A EP99124315 A EP 99124315A EP 1005910 A2 EP1005910 A2 EP 1005910A2
Authority
EP
European Patent Office
Prior art keywords
liner
tube
seal plug
closure
septum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99124315A
Other languages
German (de)
English (en)
Other versions
EP1005910A3 (fr
Inventor
C. Dicesare Paul
P. Radziunas Jeffrey
Karg Jeffrey
Lin Fu-Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of EP1005910A2 publication Critical patent/EP1005910A2/fr
Publication of EP1005910A3 publication Critical patent/EP1005910A3/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/15003—Source of blood for venous or arterial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150221—Valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150236—Pistons, i.e. cylindrical bodies that sit inside the syringe barrel, typically with an air tight seal, and slide in the barrel to create a vacuum or to expel blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150251—Collection chamber divided into at least two compartments, e.g. for division of samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150351—Caps, stoppers or lids for sealing or closing a blood collection vessel or container, e.g. a test-tube or syringe barrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150572—Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150755—Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
    • A61B5/154—Devices using pre-evacuated means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/0003—Making of sedimentation devices, structural details thereof, e.g. prefabricated parts
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/26—Separation of sediment aided by centrifugal force or centripetal force
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/26—Separation of sediment aided by centrifugal force or centripetal force
    • B01D21/262—Separation of sediment aided by centrifugal force or centripetal force by using a centrifuge
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021—Test tubes specially adapted for centrifugation purposes
    • B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2221/00—Applications of separation devices
    • B01D2221/10—Separation devices for use in medical, pharmaceutical or laboratory applications, e.g. separating amalgam from dental treatment residues
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/042—Caps; Plugs

Definitions

  • This invention relates to a device and method for separating heavier and lighter fractions of a fluid sample. More particularly, this invention relates to a device and method for collecting and transporting fluid samples whereby the device and fluid sample are subjected to centrifugation to cause separation of the heavier fraction from the lighter fraction of the fluid sample.
  • Diagnostic tests may require separation of a patient's whole blood sample into components, such as serum or plasma, the lighter phase component, and red blood cells, the heavier phase component.
  • Samples of whole blood are typically collected by venipuncture through a cannula or needle attached to a syringe or an evacuated collection tube. Separation of the blood into serum or plasma and red blood cells is then accomplished by rotation of the syringe or tube in a centrifuge.
  • Such arrangements use a barrier for moving into an area adjacent the two phases of the sample being separated to maintain the components separated for subsequent examination of the individual components.
  • a variety of devices have been used in collection devices to divide the area between the heavier and lighter phases of a fluid sample.
  • the most widely used device includes thixotropic gel materials such as polyester gels in a tube.
  • the present polyester gel serum separation tubes require special manufacturing equipment to prepare the gel and to fill the tubes.
  • the shelf-life of the product is limited in that overtime globules may be released from the gel mass.
  • These globules have a specific gravity that is less than the separated serum and may float in the serum and may clog the measuring instruments, such as the instrument probes used during clinical examination of the sample collected in the tube. Such clogging can lead to considerable downtime for the instrument to remove the clog.
  • a separator device that (i) is easily used to separate a blood sample; (ii) is independent of temperature during storage and shipping; (iii) is stable to radiation sterilization; (iv) employs the benefits of a thixotropic gel barrier yet avoids the many disadvantages of placing a gel in contact with the separated blood components; (v) minimizes cross contamination of the heavier and lighter phases of the sample during centrifugation; (vi) minimizes adhesion of the lower and higher density materials against the separator device; (vii) can be used with standard sampling equipment; (viii) is able to move into position to form a barrier in less time than conventional methods and devices; and (ix) is able to provide a clearer specimen with less cell contamination than conventional methods and devices.
  • the present invention is a method and assembly for separating a fluid sample into a higher specific gravity phase and a lower specific gravity phase.
  • the assembly of the present invention comprises a plurality of constituents.
  • the assembly comprises a container, a liner and a composite element.
  • the container may be a conventional tube having a closed bottom, an opened top and a rigid cylindrical wall extending therebetween.
  • the tube may include an inwardly directed rim near the open top.
  • the assembly further comprises a liner having a closed bottom, an open top and a tubular side wall.
  • the liner is positioned in the tube such that the closed bottom of the liner is near the closed bottom of the tube.
  • the liner in an unbiased condition, is cross-sectionally dimensioned along most of its length to lie in spaced relationship to the tube.
  • the liner may include an outwardly directed flange substantially adjacent the top of the liner. The flange may be dimensioned for engagement against the rim of the tube to position the liner longitudinally within the tube.
  • the stiffness coefficient is about .003 to about 190.
  • the liner has a thickness of about 1.0mm to about 2.5mm, a modulus of elasticity of about 13.8 MPa to about 69 MPa.
  • the assembly of the present invention will function under load created by an applied acceleration of about 300g to about 3000g.
  • the liner deforms due to hydrostatic pressure under applied acceleration and returns to its initial state upon removal of the acceleration, thereby forming a seal by constricting the seal plug which is positioned in a target density region between the higher density portion and the lower density portion of a fluid sample.
  • the assembly further includes a tube closure that is sealingly engageable in the open top of the tube.
  • the tube closure may include a tube end seat having an outside diameter at least equal to the outside diameter of the tube for disposition substantially adjacent the open top of the tube.
  • the tube closure may include a tube stopper dimensioned for sealed engagement in portions of the tube between the top of the tube and the top of the liner.
  • the tube closure may further include a liner stopper dimensioned for sealing engagement in the open top of the liner.
  • a plug recess extends into the bottom end of the tube closure.
  • the entry to the plug recess may have a plurality of inwardly extending circumferentially spaced flexible walls.
  • the composite element comprises a seal plug.
  • the seal plug may be a single constituent or a plurality of constituents and comprises a specific density at a target density range as defined by separable fluid components densities.
  • the seal plug may migrate freely when under an applied acceleration to settle at a location in the fluid sample in the target density region and thereby become a barrier at a desired level between the components of the fluid sample after the acceleration is removed.
  • the seal plug has an aggregate specific gravity of about 1.028 to about 1.09. Most preferably, the seal plug has an aggregate specific gravity so that it will rest after centrifugal force, between the heavier and lighter phases of a blood sample.
  • the seal plug preferably has an overall density between the densities of two phases of a blood sample.
  • the seal plug comprises a hard plastic shell having opposed first and second ends and an aperture extending between the ends. Outer circumferential portions of the hard plastic shell in proximity to the first end are dimensioned and configured for releasable engagement within the plug recess of the tube closure. Outer circumferential portions of the hard plastic shell in proximity to the second end are dimensioned for sealing engagement by the unbiased tube liner.
  • the seal plug further includes an elastomeric septum that is securely mounted around the first end of the hard plastic shell to provide a pierceable barrier extending across the central passage through the shell.
  • the seal plug comprises an overall specific gravity at a target specific gravity of ⁇ t.
  • the target specific gravity is that required to separate a fluid sample into two phases.
  • a fluid sample enters the assembly by a needle.
  • the needle penetrates the closure and through the elastomeric septum on the seal plug for delivering a fluid sample into the liner.
  • the needle is withdrawn from the assembly and the assembly is subjected to centrifugation. Forces exerted by the centrifuge cause the seal plug to separate from the tube closure and cause the liner to expand outwardly against the tube. Centrifugal forces then cause the seal plug to move through the expanded liner and toward the closed bottom of the tube. Sufficient movement will cause the seal plug to contact the fluid. Air trapped in the passage through the hard plastic liner and between the fluid and the elastomeric septum could create a buoyancy that might prevent further sinking of the seal plug into the fluid.
  • the trapped air will be vented through a defect in the septum, such as the defect caused by the needle cannula.
  • This venting of air permits further movement of the seal plug into the fluid.
  • the phases of the fluid will be separating such that the heavier phase component of the fluid will concentrate closer to the closed bottom, and such that the lighter phase component of the fluid will be closer to the open top.
  • the seal plug will move primarily through the lighter phase component and toward the heavier phase component of the fluid.
  • the centrifuge may be stopped after the seal plug stabilizes between the separate phases of the fluid.
  • the liner Upon termination of the centrifugal load, the liner will resiliently return toward its unexpanded condition and will sealingly engage outer circumferential regions of the seal plug. As a result, the phases of the fluid sample are isolated from one another by the seal plug and may be separated for subsequent analysis.
  • the higher specific gravity portion that contains the cellular components is between the separator and the bottom of the container after centrifugation.
  • the lower specific gravity portion that contains the cell-free serum fraction or plasma is between the top surface of the separator and the top of the container after centrifugation.
  • the separator is able to substantially eliminate the presence of red blood cells in the lower specific gravity portion and the lower specific gravity is substantially free of cellular contamination.
  • the assembly of the present invention is advantageous over existing separation products that use gel.
  • the assembly of the present invention will not interfere with analytes as compared to gels that may interfere with analytes.
  • Another attribute of the present invention is that the assembly of the present invention will not interfere with therapeutic drug monitoring analytes.
  • Another notable advantage of the present invention is that fluid specimens are not subjected to low density gel residuals that are at times available in products that use gel.
  • a further attribute of the present invention is that there is no interference with instrument probes.
  • Another attribute of the present invention is that samples for blood banking tests are more acceptable than when a gel separator is used.
  • Another attribute of the present invention is that only the substantially cell-free serum fraction of a blood sample is exposed to the top surface of the separator, thus providing practitioners with a clean sample.
  • the assembly of the present invention does not require any additional steps or treatment by a medical practitioner whereby a blood or fluid sample is drawn in the standard fashion, using standard sampling equipment.
  • FIG. 1 is a perspective view of a blood collection tube device in accordance with the subject invention.
  • FIG. 2 is a cross-sectional view taken along line 2-2 in Fig. 1.
  • FIG. 3 is a cross-sectional view similar to Fig. 2, but showing the device after insertion of a blood sample therein by a needle cannula.
  • FIG. 4 is a cross-sectional view similar to Figs. 2 and 3, but showing the device at an early stage during centrifugation.
  • FIG. 5 is a cross-sectional view similar to Fig. 4, but showing the device at a later stage during centrifugation.
  • FIG. 6 is a cross-sectional view similar to Fig. 5, but showing the device upon completion of centrifugation, and with the respective phases of blood separated.
  • FIG. 7 is an enlarged cross-sectional view of portions of the device adjacent the seal plug during the early stages of centrifugation, as shown in Fig. 4.
  • FIG. 8 is an enlarged cross-sectional view of portions of the device adjacent the seal plug at a later stage during centrifugation, as shown in Fig. 5.
  • FIG. 9 is an exploded perspective view of the device.
  • FIGS. 1 to 9 The preferred apparatus of the present invention is illustrated in FIGS. 1 to 9, wherein device 10 comprises a tube 12 , an elastomeric liner 22 , a closure 34 , and a seal plug assembly 64 .
  • Device 10 includes rigid plastic tube 12 having an open top 14 , a closed bottom 16 and a cylindrical sidewall 18 .
  • Sidewall 18 defines a constant inside diameter "a" along a major portion of its length.
  • Device 10 further includes an elastomeric liner 22 having an open top 24 , a closed bottom 26 and a tubular sidewall 28 .
  • Side wall 28 in an unbiased condition, defines an inside diameter "c” and an outside diameter “d” along a major portion of the length of liner 22 .
  • Outside diameter "d” is less than inside diameter "a" of sidewall 18 on tube 12 , and is approximately equal to or slightly less than inside diameter "b" of rim 20 .
  • Liner 22 is characterized by an outwardly directed flange 30 adjacent open top 24 . Portions of flange 30 immediately adjacent open top 24 are cylindrically generated and define an outside diameter "e”.
  • portions of flange 30 spaced from open top 24 taper to outside diameter "d" which exists elsewhere on sidewall 28 .
  • Diameter “e” of flange 30 is greater than inside diameter "b" of rim 20 on tube 12 , and is approximately equal to or slightly less than inside diameter "a” existing at locations on tube 12 between rim 20 and open top 14 thereof.
  • portions of liner 22 below flange 30 can be slid through rim 20 on tube 12 .
  • flange 30 can be slid into portions of tube 12 between rim 20 and open top 14 .
  • flange 30 will interfere with rim 20 and will prevent liner 22 from sliding entirely past rim 20 .
  • the length of liner 22 is selected to ensure that closed bottom 26 of liner 22 is spaced slightly from closed bottom 16 of tube 12 when flange 30 of liner 22 engages rim 20 of tube 12 .
  • vent slits 31 enable an escape of air from the space between liner 22 and tube 12 during assembly, and thereby facilitates the complete insertion of liner 22 into tube 12 .
  • Device 10 further includes a tube closure that can be pierced by a needle cannula and that will reseal itself after removal of the needle cannula.
  • Tube closure 34 includes a top end 36 and a bottom end 38 .
  • Top end 36 of tube closure 34 is characterized by a central recess 40 which defines a target area for piercing by a needle cannula.
  • a radially aligned tube end seat 42 is defined between top and bottom ends 36 and 38 and faces toward bottom end 38 .
  • Tube end seat 42 defines an outside diameter that exceeds the outside diameter of tube 12 .
  • tube end seat 42 can be sealingly engaged against open top end 14 of tube 12 .
  • a liner end seat 44 is defined on tube closure 34 at a distance below tube end seat 42 to ensure that liner end seat 44 is substantially adjacent open top end 24 of liner 22 when tube end seat 42 is adjacent to open top end 14 of tube 12 .
  • Portions of tube stopper 46 adjacent liner end seat 44 define a diameter approximately equal to inside diameter "a" of tube 12 .
  • Portions of tube stopper 46 closer to tube end seat 42 define a larger diameter. Consequently, tube stopper 46 is compressed during insertion into tube 14 for achieving a tight sealing engagement.
  • a liner stopper 48 extends from liner end seat 44 to bottom end 38 of tube closure 34 .
  • Liner stopper 48 has a cylindrical outer surface along most of its length with an outside diameter slightly greater than inside diameter "c" of liner 22 . However, portions of liner stopper 48 adjacent bottom end 38 are chamfered to a diameter that is less than inside diameter "c" of liner 22 . The chamfered bottom end of liner stopper 48 facilitates the inward compression required to urge liner stopper 48 of tube closure 34 into open top end 24 of liner 22 .
  • Liner stopper 48 is further characterized by at least one axially extending vent groove 50 to permit venting of gas from liner 22 during insertion of tube closure 34 .
  • Tube closure 34 is further characterized by a plug recess 52 extending axially into bottom end 38 .
  • the entrance to plug recess 52 is defined by a plurality of circumferentially spaced flexible release walls 54 that have inner surfaces 56 generated as part of a single cylinder with a diameter "f".
  • Each flexible release wall 54 further includes a chamfered surface 58 extending from the cylindrically generated surface 56 to the bottom end 38 of tube closure 34 .
  • Flexible release walls 54 each also include a radially aligned plug-gripping surface 60 facing into plug recess 52 .
  • the top central portion of plug recess 52 is defined by downwardly pointing conical surface 62 .
  • Device 10 further includes a seal plug assembly 64 which comprises a generally tubular hard plastic shell 66 and an elastomeric septum 68 .
  • the components of seal plug assembly 64 are formed from materials to exhibit a combined density less than the density of the red blood cells, but greater than the density of the serum.
  • Shell 66 includes a top end 70 , a bottom end 72 and a central passage 74 extending continuously between the ends.
  • Annular sealing ribs 76 and 78 extend outwardly from shell 66 at locations near bottom end 72 .
  • Annular sealing ribs 76 and 78 define diameters approximately equal to inside diameter "c" of liner 22 .
  • Shell 66 further includes an outwardly projecting annular septum flange 80 substantially adjacent top end 70 and an annular closure engagement wall 82 between sealing flange 78 and septum flange 80 .
  • Closure engagement wall 82 defines an outside diameter that is substantially equal to the inside diameter of plug recess 52 of tube closure 34 .
  • a cylindrical wall 84 extends between closure engagement wall 82 and sealing flange 78 .
  • Cylindrical wall 84 defines an outside diameter approximately equal to the inside diameter "f" defined by flexible release walls 54 of tube closure 34 .
  • cylindrical wall 84 defines a length approximately equal to the axial length of cylindrically generated portions 56 of flexible release walls 54 .
  • Elastomeric septum 68 is molded unitarily from a rupturable elastomeric material such as Kraton copolymer, a urethane or PVC.
  • Septum 68 includes a bottom 86 , a generally cylindrical side wall 88 extending upwardly from bottom wall 86 and an initially conically convex top wall 90 extending upwardly from cylindrical side wall 88 .
  • a shell recess 92 extends centrally into bottom 86 of septum 68 .
  • Shell recess 92 includes a small diameter entry having a length substantially equal to the axial distance between septum flange 80 and closure engaging flange 82 on shell 66 .
  • Shell recess 92 further includes a large diameter portion that dimensionally conforms to axial and diametric dimensions of septum flange 80 on shell 66 .
  • Device 10 is assembled by slidably inserting liner 22 into shell 12 until flange 30 of liner 22 is seated against annular rim 20 of tube 12 .
  • outside diameter "d" of cylindrical side wall 28 of liner 22 is less than inside diameter "a” of cylindrical side wall 18 of tube 12 . Accordingly, an annular space will exist between liner 22 and tube 12 at locations between annular rim 20 of tube 12 and closed bottom 16 thereof.
  • Seal plug 64 then may be assembled by mounting elastomeric septum 68 over top 70 of shell 66 . More particularly, septum flange 80 is forcibly urged into shell recess 92 in open bottom 86 of septum 68 . Small diameter portions of recess 92 will resiliently engage around portions of shell 66 between septum flange 80 and closure engagement flange 82 . Seal plug assembly 64 then is urged into plug recess 52 in bottom end 38 of tube closure 34 . This will require an initial outward stretching of portions of tube closure 34 adjacent bottom end 38 . However, tube closure 34 will resiliently return toward an undeflected condition with flexible release walls 54 engaged around cylindrical wall 84 between closure engagement flange 82 and annular sealing flange 78 . Additionally, conical surface 62 in shell recess 52 of tube closure 34 will cause convexly conical top wall 90 of septum 68 to deflect into concave configuration in nested engagement with conical surface 62 .
  • closure 34 and seal plug 64 then is inserted into open top end 14 of tube 12 . Sufficient insertion causes annular sealing flanges 76 and 78 of shell 66 to sealingly engage in liner 22 .
  • Liner end seat 44 will seat substantially adjacent open top 24 of liner 22 .
  • Tube stopper 46 will compress into tight sealing engagement with inner circumferential portions of tube 12 between liner 22 and open top 14 of tube 12 . Insertion of tube closure 43 into tube 12 will terminate when tube end seat 42 seats against open top 14 of tube 12 .
  • a needle cannula 94 is used to insert a sample of blood into device 10 . More particularly, as shown most clearly in Fig. 3 , needle cannula 94 is urged centrally into recess 40 at top end 36 of tube closure 34 . Continued advancement of needle cannula 94 will cause a rupturing of conical top wall 90 of septum 68 . An appropriate volume of blood 96 then is delivered from needle cannula 94 into liner 22 . Portions of tube closure 34 adjacent recess 40 will self-seal upon removal of needle cannula 94 . However, conical top wall 90 of septum 68 will remain with a defect.
  • Device 10 with blood 96 therein then is placed in a centrifuge which places a centrifugal load on device 10 .
  • the centrifugal load deflects flexible release walls 54 sufficiently downwardly to permit separation of seal plug assembly 64 from tube closure 34 .
  • the centrifugal load causes an outward deflection of tubular sidewall 28 of elastomeric tube liner 22 .
  • This outward deflection of liner 22 permits seal plug 64 to move toward closed bottoms 26 and 16 of liner 22 and tube 12 respectively.
  • Air will be trapped in passage 74 of shell 66 approximately when bottom end 72 of shell 66 contacts blood 96 . This trapped air could restrict further downward movement of seal plug 64 .
  • the defect in septum 68 caused by needle cannula 94 defines a path through which trapped air may escape passage 74 .
  • seal plug 64 is permitted to sink into blood 96 .
  • the centrifugal load created by the centrifuge also separates serum from red blood cells in blood 96 .
  • red blood cells under the action of the centrifugal load, migrate around seal plug assembly 64 and toward closed bottom 26 of liner 22 .
  • the less dense serum of blood 96 will flow between shell 66 and outwardly deformed portions of elastomeric liner 22 as shown schematically in Fig. 5 .
  • Seal plug 64 will stabilize at a position in liner 22 between the red blood cells and the serum of blood 96 . This stabilized position is attributable to the formation of seal plug 66 and septum 68 from materials that will give seal plug 64 a density less than the density of the red blood cells, but greater than the density of the serum. After a specified time, the centrifuge will be stopped. The absence of the centrifugal load will cause side wall 28 of elastomeric liner 22 to resiliently return toward an undeformed condition and into tight sealing engagement with annular sealing flanges 76 and 78 of shell 66 . Thus, red blood cells 98 will be sealed between seal plug 64 and closed bottom 26 of liner 22 , while serum 100 will lie between seal plug 64 and closure 34 .
  • Liner 22 is compatible with most of the numerous additives used in sample collection tubes such as citrates, silicates. EDTA and the like that are used to condition the fluid sample either to facilitate or retard clotting, or to preserve the fluid sample for a particular analysis. It is within the purview of this invention that one or more additives may be used in the present invention for particular applications.
  • additives used in sample collection tubes such as citrates, silicates. EDTA and the like that are used to condition the fluid sample either to facilitate or retard clotting, or to preserve the fluid sample for a particular analysis. It is within the purview of this invention that one or more additives may be used in the present invention for particular applications.
  • the separator of the present invention was made as follows: The three components of the separator, a liner, a septum, a seal plug were made by injection molding.
  • the liner was made from DuPont Dow Engage® 8400 polyolefin elastomer with a flexural modulus of 22 MPa.
  • the septum was made from GLS Dynaflex® 2712 (Dynaflex is a trademark of and manufactured by GLS Corp., Cory, Ill.), with a specific gravity of 0.889.
  • the seal plug was made from Bayer Lustran® 348 ABS with a specific gravity of 1.06.
  • the separator of the present invention was made as follows: The two components of the separator, the liner was injection molded from DuPont Dow Engage® 8411 polyolefin elastomer with a flexural modulus of 29 MPa and the seal plug was injection molded from Bayer Lustran® 348 with a specific gravity of 1.06.
  • the separator of the present invention was made as follows: The three components of the separator, the liner was injection molded from DuPont Dow Engage® 8411 polyolefin elastomer with a flexural modulus of 29 MPa and the septum was made from a Kraton® elastomer and the seal plug injection molded from Bayer Lustram® 348 with a specific gravity of 1.06.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • Analytical Chemistry (AREA)
  • Ecology (AREA)
  • Clinical Laboratory Science (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Centrifugal Separators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
EP99124315A 1998-12-05 1999-12-06 Tube centrifuge avec élément de séparation à symmétrie cylindrique, garniture et bouchon Withdrawn EP1005910A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11092798P 1998-12-05 1998-12-05
US110927P 1998-12-05

Publications (2)

Publication Number Publication Date
EP1005910A2 true EP1005910A2 (fr) 2000-06-07
EP1005910A3 EP1005910A3 (fr) 2002-06-12

Family

ID=22335695

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99124315A Withdrawn EP1005910A3 (fr) 1998-12-05 1999-12-06 Tube centrifuge avec élément de séparation à symmétrie cylindrique, garniture et bouchon

Country Status (3)

Country Link
US (1) US6516953B1 (fr)
EP (1) EP1005910A3 (fr)
JP (1) JP4398032B2 (fr)

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002237A1 (fr) * 2000-06-30 2002-01-10 Beckman Coulter, Inc. Revetement conforme amovible pour recipients de centrifugeuse
WO2002078848A2 (fr) * 2001-03-30 2002-10-10 Greiner Bio-One Gmbh Dispositif de reception notamment pour liquides organiques, muni d'un dispositif de separation et dispositif de separation correspondant
WO2003092894A2 (fr) * 2002-05-03 2003-11-13 Hanuman Llc Procede et appareil d'isolation de plaquettes sanguines
WO2004031770A1 (fr) 2002-10-03 2004-04-15 Battelle Memorial Institute Tube pour couche leuco-plaquettaire et procede et systeme a flotteur
WO2004030826A2 (fr) 2002-10-03 2004-04-15 Battelle Memorial Institute Procede et systeme a flotteur de separation de couche leuco-plaquettaire
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7780860B2 (en) 2002-05-24 2010-08-24 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2277625A1 (fr) 2004-01-23 2011-01-26 Greiner Bio-One GmbH Dispositif de retenue pour le sang, les liquides organiques, des échantillons de tissus ou de cultures de tissus
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
WO2012026970A3 (fr) * 2010-08-21 2012-05-24 Chapman John R Centrifugeuse et récipient de séparation s'y rapportant
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8394342B2 (en) 2008-07-21 2013-03-12 Becton, Dickinson And Company Density phase separation device
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US8747781B2 (en) 2008-07-21 2014-06-10 Becton, Dickinson And Company Density phase separation device
US8794452B2 (en) 2009-05-15 2014-08-05 Becton, Dickinson And Company Density phase separation device
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
CN104588140A (zh) * 2008-07-21 2015-05-06 贝克顿·迪金森公司 密度相分离装置
EP2928374A4 (fr) * 2012-12-05 2017-04-12 Theranos, Inc. Systèmes, dispositifs et procédés de collecte et de transport d'échantillons de liquides organiques
US9636062B2 (en) 2012-09-06 2017-05-02 Theranos, Inc. Systems, devices, and methods for bodily fluid sample collection
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
US9701728B2 (en) 2008-02-27 2017-07-11 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9877674B2 (en) 2012-09-06 2018-01-30 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample collection
CN107684774A (zh) * 2017-09-29 2018-02-13 广州市雷德生物科技有限公司 一种过滤装置
US9897589B2 (en) 2002-05-24 2018-02-20 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10248765B1 (en) 2012-12-05 2019-04-02 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample collection, transport, and handling
US10244973B2 (en) 2012-12-05 2019-04-02 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample transport
US10371606B2 (en) 2015-07-21 2019-08-06 Theraos IP Company, LLC Bodily fluid sample collection and transport
US10576130B2 (en) 2013-03-15 2020-03-03 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US10856791B2 (en) 2014-03-12 2020-12-08 Labrador Diagnostics Llc Systems, devices, and methods for bodily fluid sample collection
CN112806993A (zh) * 2021-01-11 2021-05-18 德阳市人民医院 一种采血试管组件
EP3847965A1 (fr) * 2015-12-11 2021-07-14 Babson Diagnostics, Inc. Récipient d'échantillon et procédé de séparation de sérum ou de plasma à partir du sang entier
US11278884B2 (en) 2014-10-28 2022-03-22 Arteriocyte Medical Systems, Inc. Centrifuge tube comprising a floating buoy, and methods for using the same
CN115475412A (zh) * 2022-10-20 2022-12-16 深圳瑞亚力集团有限公司 一种液滴生成油提纯方法
US12025629B2 (en) 2023-04-14 2024-07-02 Babson Diagnostics, Inc. Automated centrifuge loader

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947236B2 (en) * 1999-12-03 2011-05-24 Becton, Dickinson And Company Device for separating components of a fluid sample
US6354452B1 (en) * 2000-07-25 2002-03-12 Becton, Dickinson And Company Collection container assembly
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
MXPA04011129A (es) 2002-05-13 2005-02-17 Becton Dickinson Co Sistema de recoleccion de muestra de inhibidor de proteasa.
US20060212020A1 (en) 2002-10-10 2006-09-21 Lynne Rainen Sample collection system with caspase inhibitor
ES2347564T3 (es) 2003-08-05 2010-11-02 Becton, Dickinson And Company Dispositivo y metodos para la recogida de una muestra de fluido biologico y el tratmaiento de componentes seleccionados.
US20050124965A1 (en) * 2003-12-08 2005-06-09 Becton, Dickinson And Company Phosphatase inhibitor sample collection system
ES2426941T3 (es) * 2005-02-07 2013-10-25 Hanuman Llc Aparato y procedimiento de concentrados de plasma rico en plaquetas
EP1848473B1 (fr) * 2005-02-07 2013-05-22 Hanuman LLC Dispositif concentrateur de plasma
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US20070003449A1 (en) * 2005-06-10 2007-01-04 Mehdi Hatamian Valve for facilitating and maintaining fluid separation
US8048678B2 (en) * 2005-10-27 2011-11-01 Ecw Therapeutics, Inc. Cell separation method and apparatus
WO2007050986A1 (fr) * 2005-10-27 2007-05-03 Neil Duffy Procede et appareil de separation de cellules
US8272255B2 (en) 2006-05-22 2012-09-25 3M Innovative Properties Company System and method for preparing samples
JP2011502545A (ja) * 2007-11-20 2011-01-27 スリーエム イノベイティブ プロパティズ カンパニー 試料調製容器及び方法
BRPI0819280A2 (pt) * 2007-11-20 2015-05-19 3M Innovative Properties Co Preparação de amostra para amostragem ambiental
CN101909755B (zh) * 2007-11-20 2013-09-18 3M创新有限公司 样品制备容器和方法
US8647574B2 (en) * 2007-11-20 2014-02-11 3M Innovative Properties Company Sample preparation container and method
CA2846168C (fr) * 2008-03-05 2016-12-13 Becton, Dickinson And Company Ensemble recipient et dispositif de collecte a action capillaire
US20100093551A1 (en) * 2008-10-09 2010-04-15 Decision Biomarkers, Inc. Liquid Transfer and Filter System
US8177072B2 (en) * 2008-12-04 2012-05-15 Thermogenesis Corp. Apparatus and method for separating and isolating components of a biological fluid
WO2010138895A2 (fr) 2009-05-29 2010-12-02 Neil Francis Duffy Appareil et procédés permettant d'aspirer et de séparer des composants de densité différente d'un liquide physiologique contenant des cellules
KR101069877B1 (ko) * 2009-10-28 2011-10-05 임기표 원심분리 키트 및 이를 이용한 원심분리 방법
CA2795008A1 (fr) * 2010-03-30 2011-10-13 Battelle Memorial Institute Systemes et procedes a flotteur pour separation de la couche leucocyto-plaquettaire
EP2553421A1 (fr) * 2010-03-30 2013-02-06 Battelle Memorial Institute Systèmes et procédés à flotteur pour séparation de la couche leucocyto-plaquettaire
US9028425B2 (en) * 2010-07-15 2015-05-12 Becton, Dickinson And Company Vented blood sampling device
CN203203992U (zh) 2011-03-04 2013-09-18 贝克顿·迪金森公司 包含溶血磷脂酶抑制剂的血液收集装置
WO2013045695A2 (fr) 2011-09-30 2013-04-04 Pz Cormay S.A. Procédé pour distribuer un échantillon de fluide corporel dans un système d'analyse, seringue conçue pour utilisation dans celui-ci et kit comprenant une telle seringue
US9427707B2 (en) 2012-08-10 2016-08-30 Jean I. Montagu Filtering blood
PL400953A1 (pl) 2012-09-27 2014-03-31 Scope Fluidics Spółka Z Ograniczoną Odpowiedzialnością Układ mikroprzepływowy i sposób dostarczania próbki płynu ustrojowego do układu analizującego z zastosowaniem układu mikroprzepływowego
US10603665B2 (en) 2013-01-29 2020-03-31 Endocellutions, Inc. Cell concentration devices and methods that include an insert defining a lumen and a cannula assembly
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US20160136639A1 (en) * 2014-11-13 2016-05-19 Becton, Dickinson And Company Mechanical Separator for a Biological Fluid
FR3036954B1 (fr) * 2015-06-03 2017-07-14 Imv Tech Paillette pour la conservation d'une dose predeterminee de substance a base liquide, ainsi que dispositif d'injection et procede la mettant en oeuvre
CN107921445A (zh) * 2015-09-07 2018-04-17 曼·胡默尔有限公司 用于离心分离器的转子的带密封件的内衬
PL237582B1 (pl) * 2015-09-15 2021-05-04 Spark Tech Spolka Z Ograniczona Odpowiedzialnoscia Insert do pojemnika do wirowania, zwłaszcza, do probówki, do wydzielenia frakcji o pożądanym zakresie gęstości metodą wirowania na gradiencie gęstości oraz pojemnik do wirowania zawierający ten insert
EP4309789A2 (fr) * 2016-03-17 2024-01-24 Kazemzadeh, Amin Dispositifs microfluidiques de stockage sur puce
US11883817B2 (en) 2017-01-25 2024-01-30 Yantai Ausbio Laboratories Co., Ltd. Equipment and methods for automated sample processing for diagnostic purposes
PL421074A1 (pl) 2017-03-31 2018-10-08 Pz Cormay Spółka Akcyjna Układ mikroprzepływowy
DE102017108933B4 (de) * 2017-04-26 2018-12-06 Sarstedt Aktiengesellschaft & Co.Kg Trennkörper
US11344880B2 (en) 2018-11-30 2022-05-31 Hans-Werner Heinrich Centrifuge tube separation system, and methods of use
CA3182142A1 (fr) * 2020-07-15 2022-01-20 Prp Technologies, Inc. Dispositif, kit et procedes de creation de plasma riche en plaquettes
US11135580B1 (en) * 2020-07-15 2021-10-05 Prp Technologies Inc Device, kit and methods for creating platelet rich plasma

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3779383A (en) * 1972-04-25 1973-12-18 Becton Dickinson Co Sealed assembly for separation of blood components and method
US3897343A (en) * 1974-02-27 1975-07-29 Becton Dickinson Co Plasma separator-hydrostatic pressure type
US4426290A (en) * 1980-05-08 1984-01-17 Terumo Corporation Apparatus for separating blood
EP0638804A1 (fr) * 1993-08-13 1995-02-15 Niigata Chemicals And Plastics Co. Ltd Appareil de séparation du sérum
WO1998051411A2 (fr) * 1997-05-12 1998-11-19 C.A. Greiner & Söhne Gesellschaft Mbh Dispositif de separation dans un recipient centrifugable et procede de separation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849072A (en) 1972-04-25 1974-11-19 Becton Dickinson Co Plasma separator
US4083788A (en) 1975-11-19 1978-04-11 Ferrara Louis T Blood serum-isolation device
US4088582A (en) 1976-01-16 1978-05-09 Sherwood Medical Industries Inc. Blood phase separation means
AT381466B (de) 1977-03-16 1986-10-27 Ballies Uwe Trennroehrchen fuer zentrifugaltrennung
US4131549A (en) 1977-05-16 1978-12-26 Ferrara Louis T Serum separation device
US4257886A (en) 1979-01-18 1981-03-24 Becton, Dickinson And Company Apparatus for the separation of blood components
DE3069996D1 (en) 1979-03-23 1985-03-07 Terumo Corp A method for separating blood and a barrier device therefor
DE3101733C2 (de) 1981-01-21 1982-10-14 Uwe Dr.Med. 2300 Kiel Ballies Trennelement in einem Trennröhrchen zur Zentrifugaltrennung
US4417981A (en) 1981-05-04 1983-11-29 Becton, Dickinson And Company Blood phase separator device
US4443345A (en) 1982-06-28 1984-04-17 Wells John R Serum preparator
SE448323B (sv) 1985-08-27 1987-02-09 Ersson Nils Olof Forfarande och anordnig att separera serum eller plasma fran blod
US4818386A (en) 1987-10-08 1989-04-04 Becton, Dickinson And Company Device for separating the components of a liquid sample having higher and lower specific gravities
US4877520A (en) 1987-10-08 1989-10-31 Becton, Dickinson And Company Device for separating the components of a liquid sample having higher and lower specific gravities
US5269927A (en) 1991-05-29 1993-12-14 Sherwood Medical Company Separation device for use in blood collection tubes
JPH06222055A (ja) 1993-01-22 1994-08-12 Niigata Kako Kk 液体サンプルの成分分離用分離部材
US5389265A (en) 1993-06-02 1995-02-14 E. I. Du Pont De Nemours And Company Phase-separation tube
US5455009A (en) 1993-09-14 1995-10-03 Becton, Dickinson And Company Blood collection assembly including clot-accelerating plastic insert
US5575778A (en) * 1994-09-21 1996-11-19 B. Braun Melsungen Ag Blood-taking device
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5632905A (en) 1995-08-07 1997-05-27 Haynes; John L. Method and apparatus for separating formed and unformed components

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3779383A (en) * 1972-04-25 1973-12-18 Becton Dickinson Co Sealed assembly for separation of blood components and method
US3897343A (en) * 1974-02-27 1975-07-29 Becton Dickinson Co Plasma separator-hydrostatic pressure type
US4426290A (en) * 1980-05-08 1984-01-17 Terumo Corporation Apparatus for separating blood
EP0638804A1 (fr) * 1993-08-13 1995-02-15 Niigata Chemicals And Plastics Co. Ltd Appareil de séparation du sérum
WO1998051411A2 (fr) * 1997-05-12 1998-11-19 C.A. Greiner & Söhne Gesellschaft Mbh Dispositif de separation dans un recipient centrifugable et procede de separation

Cited By (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002237A1 (fr) * 2000-06-30 2002-01-10 Beckman Coulter, Inc. Revetement conforme amovible pour recipients de centrifugeuse
WO2002078848A2 (fr) * 2001-03-30 2002-10-10 Greiner Bio-One Gmbh Dispositif de reception notamment pour liquides organiques, muni d'un dispositif de separation et dispositif de separation correspondant
WO2002078848A3 (fr) * 2001-03-30 2002-12-27 Greiner Bio One Gmbh Dispositif de reception notamment pour liquides organiques, muni d'un dispositif de separation et dispositif de separation correspondant
US7188734B2 (en) 2001-03-30 2007-03-13 Greiner Bio-One Gmbh Holding device, particularly for bodily fluids, comprising a separating device, and a separating device therefor
US7223346B2 (en) 2002-05-03 2007-05-29 Hanuman Llc Methods and apparatus for isolating platelets from blood
WO2003092894A2 (fr) * 2002-05-03 2003-11-13 Hanuman Llc Procede et appareil d'isolation de plaquettes sanguines
WO2003092894A3 (fr) * 2002-05-03 2004-03-25 Hanuman Llc Procede et appareil d'isolation de plaquettes sanguines
US7837884B2 (en) 2002-05-03 2010-11-23 Hanuman, Llc Methods and apparatus for isolating platelets from blood
US8950586B2 (en) 2002-05-03 2015-02-10 Hanuman Llc Methods and apparatus for isolating platelets from blood
US8187477B2 (en) 2002-05-03 2012-05-29 Hanuman, Llc Methods and apparatus for isolating platelets from blood
US9897589B2 (en) 2002-05-24 2018-02-20 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8603346B2 (en) 2002-05-24 2013-12-10 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10393728B2 (en) 2002-05-24 2019-08-27 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10183042B2 (en) 2002-05-24 2019-01-22 Biomet Manufacturing, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8808551B2 (en) 2002-05-24 2014-08-19 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8062534B2 (en) 2002-05-24 2011-11-22 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7780860B2 (en) 2002-05-24 2010-08-24 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8048321B2 (en) 2002-05-24 2011-11-01 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7914689B2 (en) 2002-05-24 2011-03-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2458381A3 (fr) * 2002-10-03 2012-07-25 Battelle Memorial Institute Tube pour couche leuco-plaquettaire et procédé et systeme à flotteur
AU2003277223B8 (en) * 2002-10-03 2009-11-19 Battelle Memorial Institute Buffy coat separator float system and method
AU2003277223B2 (en) * 2002-10-03 2009-11-05 Battelle Memorial Institute Buffy coat separator float system and method
WO2004031770A1 (fr) 2002-10-03 2004-04-15 Battelle Memorial Institute Tube pour couche leuco-plaquettaire et procede et systeme a flotteur
WO2004030826A2 (fr) 2002-10-03 2004-04-15 Battelle Memorial Institute Procede et systeme a flotteur de separation de couche leuco-plaquettaire
EP1546720A4 (fr) * 2002-10-03 2009-10-28 Battelle Memorial Institute Tube pour couche leuco-plaquettaire et procede et systeme a flotteur
EP1546720A1 (fr) * 2002-10-03 2005-06-29 Battelle Memorial Institute Tube pour couche leuco-plaquettaire et procede et systeme a flotteur
EP2559991A1 (fr) * 2002-10-03 2013-02-20 Battelle Memorial Institute Système et procédé à flotteur de séparation de couche leuco-plaquettaire
EP1552270A2 (fr) * 2002-10-03 2005-07-13 Battelle Memorial Institute Procede et systeme a flotteur de separation de couche leuco-plaquettaire
EP1552270A4 (fr) * 2002-10-03 2009-12-30 Battelle Memorial Institute Procede et systeme a flotteur de separation de couche leuco-plaquettaire
EP2277625A1 (fr) 2004-01-23 2011-01-26 Greiner Bio-One GmbH Dispositif de retenue pour le sang, les liquides organiques, des échantillons de tissus ou de cultures de tissus
US8448800B2 (en) 2004-01-23 2013-05-28 Greiner Bio-One Gmbh Method for the assembly of a cap with a receptacle
US8133389B2 (en) 2005-02-07 2012-03-13 Hanuman, Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7987995B2 (en) 2005-02-07 2011-08-02 Hanuman, Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8596470B2 (en) 2007-04-12 2013-12-03 Hanuman, Llc Buoy fractionation system
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US9649579B2 (en) 2007-04-12 2017-05-16 Hanuman Llc Buoy suspension fractionation system
US8119013B2 (en) 2007-04-12 2012-02-21 Hanuman, Llc Method of separating a selected component from a multiple component material
US10400017B2 (en) 2008-02-27 2019-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9701728B2 (en) 2008-02-27 2017-07-11 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US11725031B2 (en) 2008-02-27 2023-08-15 Biomet Manufacturing, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US9719063B2 (en) 2008-02-29 2017-08-01 Biomet Biologics, Llc System and process for separating a material
US8801586B2 (en) 2008-02-29 2014-08-12 Biomet Biologics, Llc System and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
US9933344B2 (en) 2008-07-21 2018-04-03 Becton, Dickinson And Company Density phase separation device
US9339741B2 (en) 2008-07-21 2016-05-17 Becton, Dickinson And Company Density phase separation device
US10350591B2 (en) 2008-07-21 2019-07-16 Becton, Dickinson And Company Density phase separation device
US8747781B2 (en) 2008-07-21 2014-06-10 Becton, Dickinson And Company Density phase separation device
CN104588140A (zh) * 2008-07-21 2015-05-06 贝克顿·迪金森公司 密度相分离装置
US9714890B2 (en) 2008-07-21 2017-07-25 Becton, Dickinson And Company Density phase separation device
US9700886B2 (en) 2008-07-21 2017-07-11 Becton, Dickinson And Company Density phase separation device
US9452427B2 (en) 2008-07-21 2016-09-27 Becton, Dickinson And Company Density phase separation device
CN104588140B (zh) * 2008-07-21 2016-06-29 贝克顿·迪金森公司 密度相分离装置
US9333445B2 (en) 2008-07-21 2016-05-10 Becton, Dickinson And Company Density phase separation device
US8394342B2 (en) 2008-07-21 2013-03-12 Becton, Dickinson And Company Density phase separation device
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
US9182328B2 (en) 2008-12-01 2015-11-10 Baxalta Incorporated Apparatus and method for processing biological material
US9423327B2 (en) 2008-12-01 2016-08-23 Baxalta GmbH Apparatus and method for processing biological material
US9176038B2 (en) 2008-12-01 2015-11-03 Baxalta Incorporated Apparatus and method for processing biological material
US9097631B2 (en) 2008-12-01 2015-08-04 Baxter International Inc. Apparatus and method for processing biological material
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8783470B2 (en) 2009-03-06 2014-07-22 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US8992862B2 (en) 2009-04-03 2015-03-31 Biomet Biologics, Llc All-in-one means of separating blood components
US9731290B2 (en) 2009-05-15 2017-08-15 Becton, Dickinson And Company Density phase separation device
US9802189B2 (en) 2009-05-15 2017-10-31 Becton, Dickinson And Company Density phase separation device
US9079123B2 (en) 2009-05-15 2015-07-14 Becton, Dickinson And Company Density phase separation device
US11786895B2 (en) 2009-05-15 2023-10-17 Becton, Dickinson And Company Density phase separation device
US10343157B2 (en) 2009-05-15 2019-07-09 Becton, Dickinson And Company Density phase separation device
US10807088B2 (en) 2009-05-15 2020-10-20 Becton, Dickinson And Company Density phase separation device
US11351535B2 (en) 2009-05-15 2022-06-07 Becton, Dickinson And Company Density phase separation device
US9364828B2 (en) 2009-05-15 2016-06-14 Becton, Dickinson And Company Density phase separation device
US10413898B2 (en) 2009-05-15 2019-09-17 Becton, Dickinson And Company Density phase separation device
US8794452B2 (en) 2009-05-15 2014-08-05 Becton, Dickinson And Company Density phase separation device
US8998000B2 (en) 2009-05-15 2015-04-07 Becton, Dickinson And Company Density phase separation device
US10456782B2 (en) 2009-05-15 2019-10-29 Becton, Dickinson And Company Density phase separation device
US9919308B2 (en) 2009-05-15 2018-03-20 Becton, Dickinson And Company Density phase separation device
US9919307B2 (en) 2009-05-15 2018-03-20 Becton, Dickinson And Company Density phase separation device
US9919309B2 (en) 2009-05-15 2018-03-20 Becton, Dickinson And Company Density phase separation device
US10376879B2 (en) 2009-05-15 2019-08-13 Becton, Dickinson And Company Density phase separation device
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
WO2012026970A3 (fr) * 2010-08-21 2012-05-24 Chapman John R Centrifugeuse et récipient de séparation s'y rapportant
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10842424B2 (en) 2012-09-06 2020-11-24 Labrador Diagnostics Llc Systems, devices, and methods for bodily fluid sample collection
US9877674B2 (en) 2012-09-06 2018-01-30 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample collection
US9636062B2 (en) 2012-09-06 2017-05-02 Theranos, Inc. Systems, devices, and methods for bodily fluid sample collection
US10248765B1 (en) 2012-12-05 2019-04-02 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample collection, transport, and handling
US10244973B2 (en) 2012-12-05 2019-04-02 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample transport
EP2928374A4 (fr) * 2012-12-05 2017-04-12 Theranos, Inc. Systèmes, dispositifs et procédés de collecte et de transport d'échantillons de liquides organiques
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10441634B2 (en) 2013-03-15 2019-10-15 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10576130B2 (en) 2013-03-15 2020-03-03 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US11957733B2 (en) 2013-03-15 2024-04-16 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US10856791B2 (en) 2014-03-12 2020-12-08 Labrador Diagnostics Llc Systems, devices, and methods for bodily fluid sample collection
US11278884B2 (en) 2014-10-28 2022-03-22 Arteriocyte Medical Systems, Inc. Centrifuge tube comprising a floating buoy, and methods for using the same
US11759777B2 (en) 2014-10-28 2023-09-19 Arteriocyte Medical Systems, Inc. Centrifuge tube comprising a floating buoy, and methods for using the same
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US10371606B2 (en) 2015-07-21 2019-08-06 Theraos IP Company, LLC Bodily fluid sample collection and transport
US11305275B2 (en) 2015-07-21 2022-04-19 Labrador Diagnostics Llc Bodily fluid sample collection and transport
US11697114B2 (en) 2015-12-11 2023-07-11 Babson Diagnostics, Inc. Centrifugation method separating serum or plasma from whole blood using a specimen container having a cap to retain blood cells
EP3847965A1 (fr) * 2015-12-11 2021-07-14 Babson Diagnostics, Inc. Récipient d'échantillon et procédé de séparation de sérum ou de plasma à partir du sang entier
CN107684774B (zh) * 2017-09-29 2023-09-22 广州市雷德生物科技有限公司 一种过滤装置
CN107684774A (zh) * 2017-09-29 2018-02-13 广州市雷德生物科技有限公司 一种过滤装置
CN112806993A (zh) * 2021-01-11 2021-05-18 德阳市人民医院 一种采血试管组件
CN115475412A (zh) * 2022-10-20 2022-12-16 深圳瑞亚力集团有限公司 一种液滴生成油提纯方法
CN115475412B (zh) * 2022-10-20 2024-02-02 深圳瑞亚力集团有限公司 一种液滴生成油提纯方法
US12025629B2 (en) 2023-04-14 2024-07-02 Babson Diagnostics, Inc. Automated centrifuge loader

Also Published As

Publication number Publication date
JP4398032B2 (ja) 2010-01-13
US6516953B1 (en) 2003-02-11
EP1005910A3 (fr) 2002-06-12
JP2000189406A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
US6516953B1 (en) Device for separating components of a fluid sample
EP1005909B1 (fr) Tube centrifuge avec élément de séparation rond, garniture et bouchon
EP1014088B1 (fr) Appareil et procédé pour séparer des constituants d'un échantillon liquide
US7153477B2 (en) Device and method for separating components of a fluid sample
US6479298B1 (en) Device and method for separating components of a fluid sample
US6409528B1 (en) Device and method for collecting, preparation and stabilizing a sample
EP1106253B1 (fr) Appareil pour séparer des constituants d'un échantillon liquide
US6471069B2 (en) Device for separating components of a fluid sample
US6793892B1 (en) Device and method for separating components of a fluid sample
US8747781B2 (en) Density phase separation device
JP2011528620A (ja) 密度相分離装置
US20020132367A1 (en) Device and method for separating components of a fluid sample

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

RIC1 Information provided on ipc code assigned before grant

Free format text: 7B 01L 3/14 A, 7G 01N 33/49 B

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20020713

AKX Designation fees paid

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 20030408

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031021